Search results
Hepatitis B is globally underassessed and undertreated, especially among women and Asian minorities...
Medical Xpress· 4 days agoNew evidence reveals global underassessment and undertreatment of chronic hepatitis B (HBV),...
Vir Biotechnology (NASDAQ:VIR) Posts Quarterly Earnings Results, Beats Expectations By $0.51 EPS
ETF DAILY NEWS· 4 hours agoVir Biotechnology (NASDAQ:VIR – Get Free Report) posted its earnings results on Thursday. The company reported ($0.48) earnings per share for the quarter, beating the consensus estimate of ( ...
Earnings call: Vir Biotechnology reports Q1 2024 financials, pipeline progress By Investing.com
Investing.com· 2 days agoNoteworthy developments include promising preliminary data from its hepatitis B program and the...
Vir Biotechnology (VIR) Scheduled to Post Earnings on Thursday
ETF DAILY NEWS· 4 days agoVir Biotechnology (NASDAQ:VIR – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Thursday, May 2nd. Analysts expect Vir Biotechnology to post earnings ...
... Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in...
NBC 10 - FOX 14 Monroe· 5 days agoThe presentation will discuss data from the Company's Phase 2b AHFIRM trial, which evaluated the safety and efficacy of larsucosterol as a treatment for patients with severe ...
To Your Good Health: Night sweats and hot flashes continue for over two decades
The Marshall News Messenger· 3 days agoDEAR DR. ROACH: I am 72 years old and otherwise fairly healthy, but I am writing to you in...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoArbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus...
Arbutus Biopharma Corp (ABUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 2 days agoData will be shared as it becomes available from the ongoing Phase 2 studies. Q: What are the next...a Phase 2 study, following the completion of the current Phase 1 study which includes multiple ...
Will the DEA reclassify marijuana as a Schedule III drug? What change means for Kentucky.
Gannett via AOL· 5 days ago...Epilepsy or any other intractable seizure disorder Multiple sclerosis, muscle spasms, or...
More interim payments to be made to people hit by infected blood scandal
Press Association News via AOL· 4 days agoOfficials confirmed that the UK-wide compensation body, which will be arms-length of Government,...